publication venue for
- Renal radiofrequency ablation: Technique and results 2005
- Adjuvant immunotherapy in high-risk muscle invasive urothelial carcinoma: A systematic review and meta-analysis of randomized clinical trials.. S1078-1439(24)00573-8. 2024
- Comparison of patients with renal cell carcinoma in adjuvant therapy trials to a real-world population. 41:328.e15-328.e23. 2023
- Real-world use of systemic therapies in men with metastatic castration resistant prostate cancer (mCRPC) in Canada. 40:192.e1-192.e9. 2022
- The prognostic significance of nodal disease burden in patients with lymph node metastases from renal cell carcinoma. 37:302.e1-302.e6. 2019
- Depression and prostate cancer: A focused review for the clinician. 37:282-288. 2019
- Oncological and functional outcomes of sexual function–preserving cystectomy compared with standard radical cystectomy in men: A systematic review. 35:539.e17-539.e29. 2017
- Quality indicators in the management of bladder cancer: A modified Delphi study. 35:328-334. 2017
- The potential role of follicle-stimulating hormone in the cardiovascular, metabolic, skeletal, and cognitive effects associated with androgen deprivation therapy. 35:183-191. 2017
- Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01. 34:430.e1-430.e7. 2016
- Disease volume and distribution as drivers of treatment decisions in metastatic prostate cancer: From chemohormonal therapy to stereotactic ablative radiotherapy of oligometastases. 34:225-232. 2016
- The use of prognostic factors in metastatic renal cell carcinoma. 33:509-516. 2015
- Cardiovascular risk with androgen deprivation therapy for prostate cancer: Potential mechanisms. 33:464-475. 2015
- GnRH antagonist associates with less adiposity and reduced characteristics of metabolic syndrome and atherosclerosis compared with orchiectomy and GnRH agonist in a preclinical mouse model1Contributed equally and share first authorship.. 32:1126-1134. 2014
- Thromboembolic events in patients with urothelial carcinoma undergoing neoadjuvant chemotherapy and radical cystectomy. 32:975-980. 2014
- Effect of body mass index on the outcomes of patients with upper and lower urinary tract cancers treated by radical surgery: Results from a Canadian multicenter collaboration. 32:441-448. 2014
- Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy. 32:501-508. 2014
- Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: Assessment of adequate renal function and influence on outcome. 32:31.e17-31.e24. 2014
- Association of the Charlson comorbidity index and hypertension with survival in men with metastatic castration-resistant prostate cancer. 32:36.e27-36.e34. 2014
- Posttreatment prognostic nomogram for patients with metastatic urothelial cancer completing first-line cisplatin-based chemotherapy. 32:48.e1-48.e8. 2014
- Predictive factors of chronic kidney disease stage V after partial nephrectomy in a solitary kidney: a multi-institutional study. 32:28.e21-28.e26. 2014
- Efficacy of docetaxel-based chemotherapy following ketoconazole in metastatic castration-resistant prostate cancer: Implications for prior therapy in clinical trials. 31:1457-1463. 2013
- Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma. 31:1161-1165. 2013
- Serum alkaline phosphatase changes predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy. 30:607-613. 2012
- A multinomial Phase II study of lonafarnib (SCH 66336) in patients with refractory urothelial cancer☆. 23:143-149. 2005
- Defining the complications of cryoablation and radiofrequency ablation of small renal tumors: a multi-institutional review. 23:69-70. 2005
- Permanent flank bulge is a consequence of flank incision for radical nephrectomy in one half of patients. 22:36-39. 2004